Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 2, 2007, Pages 215-220

  Rosemar, Anders ^a   Ivarsson, Marie Louise ^b   Börjesson, Lars ^a   Holmdahl, Lena ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Kungsbacka Hospital   (Sweden)

Author keywords

Complicated diverticular disease; Diverticulitis; Matrix metalloproteinase; Tissue inhibitors of metalloproteinases; Tissue remodeling

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; DIVERTICULOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ASSAY; SIGMOIDECTOMY; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOPSY; COLON; DISEASE PROGRESSION; DIVERTICULITIS, COLONIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PROGNOSIS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 33846969509     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600960104     Document Type: Article

References (29)

1. Stollman NH, Raskin JB. Diverticular disease of the colon. J Clin Gastroenterol 1999;29:241-52.
2. Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, et al. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 2000;120:241-6.
3. McKaig BC, McWilliams D, Watson SA, Mahida YR. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol 2003; 162:1355-60.
4. Bamba S, Andoh A, Yasui H, Araki Y, Bamba T, Fujiyama Y. Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. J Gastroenterol 2003;38:548-54.
5. Falk P, Ivarsson ML. Examination gloves affect secretion of matrix metalloproteinases and their inhibitors from human abdominal skin fibroblasts. Wound Repair Regen 2003;11:230-4.
6. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996;111:1683-99.
7. Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 1998;152:1005-14.
8. von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000;47:63-73.
9. Okuno T, Andoh A, Bamba S, Araki Y, Fujiyama Y, Fujiyama M, et al. Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol 2002;37:317-24.
10. Parks WC. Matrix metalloproteinases in repair. Wound Repair Regen 1999;7:423-32.
11. Tarlton JF, Whiting CV, Tunmore D, Bregenholt S, Reimann J, Claesson MH, et al. The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis. Am J Pathol 2000;157:1927-35.
12. Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P, et al. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40SPARC genes. Int J Cancer 1995;64:70-5.
13. Stumpf M, Cao W, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V. Increased distribution of collagen type III and reduced expression of matrix metalloproteinase 1 in patients with diverticular disease. Int J Colorectal Dis 2001;16:271-5.
14. Brown PD. Matrix metalloproteinases in gastrointestinal cancer. Gut 1998;43:161-3.
15. Mimura T, Bateman AC, Lee RL, Johnson PA, McDonald PJ, Talbot IC, et al. Up-regulation of collagen and tissue inhibitors of matrix metalloproteinase in colonic diverticular disease. Dis Colon Rectum 2004;47:371-8; discussion: 378-9.
16. Syk I, Agren MS, Adawi D, Jeppsson B. Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model. Br J Surg 2001;88:228-34.
17. Savage FJ, Lacombe DL, Hembry RM, Boulos PB. Effect of colonic obstruction on the distribution of matrix metalloproteinases during anastomotic healing. Br J Surg 1998;85:72-5.
18. Stumpf M, Cao W, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V. Collagen distribution and expression of matrix metalloproteinases 1 and 13 in patients with anastomotic leakage after large-bowel surgery. Langenbecks Arch Surg 2002;386:502-6.
19. Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, et al. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 1999;44:17-25.
20. Louka AS, Stensby EK, Ek J, Gudjonsdottir AH, Ascher H, Sollid LM. Coeliac disease candidate genes: no association with functional polymorphisms in matrix metalloproteinase 1 and 3 gene promoters. Scand J Gastroenterol 2002;37:931-5.
21. Salmela MT, Karjalainen-Lindsberg ML, Jeskanen L, Saarialho-Kere U. Overexpression of tissue inhibitor of metalloproteinases-3 in intestinal and cutaneous lesions of graft-versus-host disease. Mod Pathol 2003;16:108-14.
22. Brynskov J, Foegh P, Pedersen G, Ellervik C, Kirkegaard T, Bingham A, et al. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut 2002;51:37-43.
23. Stallmach A, Chan CC, Ecker KW, Feifel G, Herbst H, Schuppan D, et al. Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut 2000;47:415-22.
24. Otani Y, Sakurai Y, Kameyama K, Igarashi N, Yokoyama T, Kubota T, et al. Matrix metalloproteinase gene expression in chronic gastric ulcer: a potential role of eosinophils in perforation. J Clin Gastroenterol 1997;25(Suppl 1):S101-4.
25. Tatsuguchi A, Fukuda Y, Ishizaki M, Yamanaka N. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs. Digestion 1999;60:246-54.
26. Shahin M, Konturek JW, Pohle T, Schuppan D, Herbst H, Domschke W. Remodeling of extracellular matrix in gastric ulceration. Microsc Res Tech 2001;53:396-408.
27. Langenskiold M, Holmdahl L, Falk P, Ivarsson ML. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int J Colorectal Dis 2005;20:245-52.
28. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002;3:207-14.
29. Baxter BT, Pearce WH, Waltke EA, Littooy FN, Hallett JW, Jr, Kent KC, et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg 2002;36:1-12.